Performance (Income Statement) Q3.2018 Q3.2018 Increase/(decrease) % Income Income from Sale of Goods 140,004 151,554 (11,550) (7.62) Income from Sevice 81,443 - 81,443 100.00 Cost of Sale of Goods (108,549
: Million Baht Projects Consolidated Revenue Project Revenue Increase (Decrease) % Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) 30th-Sep-19 30th-Sep-18 30th-Sep
amount to a decrease rate of 13.14 percent in 2019. The Company’s gross profit margins in 2018 – 2019 were equal to 17.14 percent and 19.89 percent, respectively. The increase in the gross profit market
period ended June 30, 2020, resulted in increase in total comprehensive income of Baht 59.64 million or 283.00% from the corresponding period of the previous year as the following details below: 1. Revenue
of following key factors: 1. Revenue from sales of electricity were THB 173 million in the third quarter of 2020, which increased by THB 81 million or 89% from the same period last year. The increase
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
more than its target, which reflected in 2019 gross margin increase by 250 bps YoY to 34.9%. Q4’19 Gross margin was slightly improved 50 bps YoY and recorded at 35.0%, despite the impact of new sugar tax
early 2018. - OSP energy drink market share was at 54%. Q4’18 M150 market share was at 37.9% increase by 90bps QOQ. C-Vitt took over leadership position in functional drink market, with Q4’18 market share
. 2Q 2019 PERFORMANCE ANALYSIS (YoY) In 2Q 2019, the Company reported a consolidated operating revenue of THB 690mn, a significant increase of 161.5% YoY from THB 264mn in 2Q 2018. The revenue comprised
7,930.03 8,296.77 Increase (Decrease) % Quarter 2 The operating result according to the consolidated financial statement for the 2 nd quarter of 2019 showed the profit (attributable to owners of the Company